Cas:99347-21-4 5-amino-1-methylpyrazole-4-carbohydrazide manufacturer & supplier

We serve Chemical Name:5-amino-1-methylpyrazole-4-carbohydrazide CAS:99347-21-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-amino-1-methylpyrazole-4-carbohydrazide

Chemical Name:5-amino-1-methylpyrazole-4-carbohydrazide
CAS.NO:99347-21-4
Synonyms:3-Amino-2-methyl-1H-pyrazole-4-carbohydrazide;4–1-methylpyrazole-5-ylamine;5-amino-1-methyl-1H-pyrazole-4-carbohydrazide;5-amino-1-methylpyrazole-4-carboxhydrazide;5-amino-1-methyl-1H-pyrazole-4-carboxhydrazide;aminomethylpyrazolecarbohydrazide
Molecular Formula:C5H9N5O
Molecular Weight:155.15800
HS Code:2933199090

Physical and Chemical Properties:
Melting point:237-240ºC
Boiling point:N/A
Density:1.63g/cm3
Index of Refraction:1.725
PSA:98.96000
Exact Mass:155.08100
LogP:0.27820

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-Amino-2-methyl-1H-pyrazole-4-carbohydrazide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,aminomethylpyrazolecarbohydrazide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4–1-methylpyrazole-5-ylamine Use and application,5-amino-1-methylpyrazole-4-carboxhydrazide technical grade,usp/ep/jp grade.


Related News: With an up-to-date working knowledge of both established biocatalytic processes and the very latest techniques, a trusted API CDMO provider can offer a suite of technical capabilities, backed by highly trained personnel and a proven track record of consistent quality and regulatory compliance. (S)-1-(L-threonyl-L-seryl-L-phenylalanyl-L-threonyl)-N-((R)-1-(((S)-1-amino-4-methyl-1-oxopentan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)pyrrolidine-2-carboxamide manufacturers CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. benzyl (S)-((1-((4-chlorophenyl)amino)-4-methyl-1-oxopentan-3-yl)oxy)carbamate suppliers Many specialty and biotech organizations are now relying on external service providers to minimize the costs of manufacturing and in-house development required to develop molecules for new drugs and their subsequent clinical trials, explains Saurabh Gurnurkar, executive director, UQUIFA. 2,2-Bis-(3,5-di-tert-butyl-4-hydroxy-benzyl)-malonic acid bis-(4-cyclohexyl-phenyl) ester vendor & factory Many specialty and biotech organizations are now relying on external service providers to minimize the costs of manufacturing and in-house development required to develop molecules for new drugs and their subsequent clinical trials, explains Saurabh Gurnurkar, executive director, UQUIFA. ,The company’s greenfield facility in Vasanthnarsapura Karnataka Industrial Area, Tumkur district, Karnataka, is under construction and is expected to be commissioned by April, 2022, well before the PLI scheme deadline of April 1, 2023.